ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

Cancer Society, Centers Explore Collaboration On Public Issued, Education, Information Activities

January 25, 1991

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

New Task Force For Nutrition Research Urged By NCAB Committee

February 19, 1982